<p>Stereotaxis Inc.（NYSEAMERICAN:STXS - 获取免费报告）董事 Paul Isaac 于 11 月 17 日星期一购买了 10,000 股该股票。每股的平均购买成本为 2.18 美元，总交易额为 21,800.00 美元。收购后，该董事直接持有公司 97,299 股股票，价值约为 212,111.82 美元。这代表了他们对该股票持有量的 11.45% 的增加。此次收购已在提交给证券交易委员会的文件中披露，相关文件可通过 SEC 网站访问。</p>
<h2>Stereotaxis 股票上涨 7.8%</h2>
<p>在周二的交易时段，NYSEAMERICAN STXS 上涨了 0.17 美元，达到了 2.29 美元。该公司的股票交易量为 694,472 股，而其平均交易量为 477,972 股。Stereotaxis Inc.的 1 年最低价为 1.54 美元，1 年最高价为 3.59 美元。该公司的 50 日移动平均价格为 2.92 美元，200 日移动平均价格为 2.54 美元。该公司的市值为 2.0809 亿美元，市盈率为-7.88，贝塔值为 1.65。</p>
<h2>机构资金流入和流出</h2>
<p>一些对冲基金最近买卖了 STXS 的股票。BNP Paribas Financial Markets 在第三季度将其在 Stereotaxis 的持股增加了 106.5%。BNP Paribas Financial Markets 现在拥有 11,461 股公司股票，价值 36,000 美元，此前在上个季度又收购了 5,910 股。XTX Topco Ltd 在第一季度购买了 Stereotaxis 的新股份，价值约 37,000 美元。Schonfeld Strategic Advisors LLC 在第三季度购买了 Stereotaxis 的新头寸，价值约 38,000 美元。Moneta Group Investment Advisors LLC 在第三季度购买了 Stereotaxis 的新头寸，价值约 43,000 美元。最后，Boothbay Fund Management LLC 在第三季度购买了 Stereotaxis 的新股份，价值约 54,000 美元。机构投资者持有公司 45.35% 的股票。</p>
<h2>华尔街分析师观点</h2>
<p>一些券商最近对 STXS 进行了评论。Roth Capital 在 11 月 12 日的研究报告中重申了对 Stereotaxis 的 “买入” 评级，并设定了 4.00 美元的目标价。瑞银集团在 11 月 5 日的研究报告中对 Stereotaxis 设定了 4.00 美元的目标价。根据 MarketBeat.com 的数据，一位投资分析师对该股票给予了买入评级，目前该公司有一个共识评级为 “买入”，平均目标价为 4.00 美元。</p>
<p><strong>获取我们对 Stereotaxis 的最新股票分析</strong></p>
<h2>关于 Stereotaxis</h2>
<p>（获取免费报告）</p>
<p>Stereotaxis, Inc 设计、制造和销售用于美国及国际介入实验室的机器人系统、仪器和信息系统。其机器人磁导航（RMN）系统包括 Genesis RMN 和 Niobe 系统，使医生能够通过提供图像引导的导管和导丝输送，完成复杂的介入程序，穿过血管和心脏腔室到达治疗部位。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，而不是 Stereotaxis</li>
<li>除了喝咖啡，还有 3 种投资咖啡的方法</li>
<li>亚马逊刚刚做了这个——而上次结果并不好</li>
<li>零售股票投资，解释</li>
<li>Stellantis 在 Jeep 上进行高风险投资</li>
<li>如何计算通货膨胀率</li>
<li>核能收益：第三季度哪些公司赢了，哪些公司输了</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Stereotaxis 吗？</h2>
<p>在考虑 Stereotaxis 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Stereotaxis 并不在名单上。</p>
<p>虽然 Stereotaxis 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

STXS

<p>Stereotaxis Inc. 董事 Paul Isaac 以每股 2.18 美元购买了 10,000 股，总计 21,800 美元，增加了 11.45% 的持股比例。购买后，他持有 97,299 股，价值 212,111.82 美元。该股票上涨了 7.8%，达到 2.29 美元。机构投资者持有 45.35% 的股份。分析师维持 “买入” 评级，目标价格为 4.00 美元。Stereotaxis 设计用于介入实验室的机器人系统</p>

<p>Stereotaxis Inc. (NYSEAMERICAN:STXS - Get Free Report) Director Paul Isaac purchased 10,000 shares of the stock in a transaction on Monday, November 17th. The shares were purchased at an average cost of $2.18 per share, for a total transaction of $21,800.00. Following the acquisition, the director directly owned 97,299 shares of the company's stock, valued at approximately $212,111.82. This represents a 11.45% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through the SEC website.</p>
<div class="lb-trans"><p>Stereotaxis Inc.（NYSEAMERICAN:STXS - 获取免费报告）董事 Paul Isaac 于 11 月 17 日星期一购买了 10,000 股该股票。每股的平均购买成本为 2.18 美元，总交易额为 21,800.00 美元。收购后，该董事直接持有公司 97,299 股股票，价值约为 212,111.82 美元。这代表了他们对该股票持有量的 11.45% 的增加。此次收购已在提交给证券交易委员会的文件中披露，相关文件可通过 SEC 网站访问。</p>
</div><h2>Stereotaxis Stock Up 7.8%</h2>
<div class="lb-trans"><h2>Stereotaxis 股票上涨 7.8%</h2>
</div><p>NYSEAMERICAN STXS traded up $0.17 during trading hours on Tuesday, reaching $2.29. The company's stock had a trading volume of 694,472 shares, compared to its average volume of 477,972. Stereotaxis Inc. has a 1 year low of $1.54 and a 1 year high of $3.59. The firm's 50-day moving average price is $2.92 and its 200-day moving average price is $2.54. The company has a market capitalization of $208.09 million, a price-to-earnings ratio of -7.88 and a beta of 1.65.</p>
<div class="lb-trans"><p>在周二的交易时段，NYSEAMERICAN STXS 上涨了 0.17 美元，达到了 2.29 美元。该公司的股票交易量为 694,472 股，而其平均交易量为 477,972 股。Stereotaxis Inc.的 1 年最低价为 1.54 美元，1 年最高价为 3.59 美元。该公司的 50 日移动平均价格为 2.92 美元，200 日移动平均价格为 2.54 美元。该公司的市值为 2.0809 亿美元，市盈率为-7.88，贝塔值为 1.65。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds have recently bought and sold shares of STXS. BNP Paribas Financial Markets lifted its holdings in shares of Stereotaxis by 106.5% in the 3rd quarter. BNP Paribas Financial Markets now owns 11,461 shares of the company's stock worth $36,000 after acquiring an additional 5,910 shares during the last quarter. XTX Topco Ltd purchased a new stake in Stereotaxis in the 1st quarter worth about $37,000. Schonfeld Strategic Advisors LLC purchased a new position in shares of Stereotaxis during the third quarter valued at approximately $38,000. Moneta Group Investment Advisors LLC bought a new position in shares of Stereotaxis during the third quarter valued at approximately $43,000. Finally, Boothbay Fund Management LLC purchased a new stake in shares of Stereotaxis in the third quarter worth approximately $54,000. Institutional investors own 45.35% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金最近买卖了 STXS 的股票。BNP Paribas Financial Markets 在第三季度将其在 Stereotaxis 的持股增加了 106.5%。BNP Paribas Financial Markets 现在拥有 11,461 股公司股票，价值 36,000 美元，此前在上个季度又收购了 5,910 股。XTX Topco Ltd 在第一季度购买了 Stereotaxis 的新股份，价值约 37,000 美元。Schonfeld Strategic Advisors LLC 在第三季度购买了 Stereotaxis 的新头寸，价值约 38,000 美元。Moneta Group Investment Advisors LLC 在第三季度购买了 Stereotaxis 的新头寸，价值约 43,000 美元。最后，Boothbay Fund Management LLC 在第三季度购买了 Stereotaxis 的新股份，价值约 54,000 美元。机构投资者持有公司 45.35% 的股票。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of brokerages recently commented on STXS. Roth Capital reissued a &#34;buy&#34; rating and set a $4.00 price target on shares of Stereotaxis in a research note on Wednesday, November 12th. UBS Group set a $4.00 target price on Stereotaxis in a research report on Wednesday, November 5th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of &#34;Buy&#34; and an average price target of $4.00.</p>
<div class="lb-trans"><p>一些券商最近对 STXS 进行了评论。Roth Capital 在 11 月 12 日的研究报告中重申了对 Stereotaxis 的 “买入” 评级，并设定了 4.00 美元的目标价。瑞银集团在 11 月 5 日的研究报告中对 Stereotaxis 设定了 4.00 美元的目标价。根据 MarketBeat.com 的数据，一位投资分析师对该股票给予了买入评级，目前该公司有一个共识评级为 “买入”，平均目标价为 4.00 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Stereotaxis</strong></p>
<div class="lb-trans"><p><strong>获取我们对 Stereotaxis 的最新股票分析</strong></p>
</div><h2>About Stereotaxis</h2>
<div class="lb-trans"><h2>关于 Stereotaxis</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.</p>
<div class="lb-trans"><p>Stereotaxis, Inc 设计、制造和销售用于美国及国际介入实验室的机器人系统、仪器和信息系统。其机器人磁导航（RMN）系统包括 Genesis RMN 和 Niobe 系统，使医生能够通过提供图像引导的导管和导丝输送，完成复杂的介入程序，穿过血管和心脏腔室到达治疗部位。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Stereotaxis</li>
<li>3 Ways To Invest In Coffee, Other Than Drinking It</li>
<li>Amazon Just Did This—and It Didn't End Well Last Time</li>
<li>Retail Stocks Investing, Explained</li>
<li>Stellantis Makes a High-Stakes Bet on Jeep</li>
<li>How to Calculate Inflation Rate</li>
<li>Nuclear Energy Earnings: Which Names Won and Lost in Q3</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，而不是 Stereotaxis</li>
<li>除了喝咖啡，还有 3 种投资咖啡的方法</li>
<li>亚马逊刚刚做了这个——而上次结果并不好</li>
<li>零售股票投资，解释</li>
<li>Stellantis 在 Jeep 上进行高风险投资</li>
<li>如何计算通货膨胀率</li>
<li>核能收益：第三季度哪些公司赢了，哪些公司输了</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Stereotaxis Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Stereotaxis 吗？</h2>
</div><p>Before you consider Stereotaxis, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Stereotaxis 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stereotaxis wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Stereotaxis 并不在名单上。</p>
</div><p>While Stereotaxis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Stereotaxis 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

内幕交易：Stereotaxis（NYSEAMERICAN:STXS）的一位董事购买了 10,000 股股票